Stan Wang | CEO & Founder, Thymmune Therapeutics
Stan Wang, MD, PhD, is CEO & Founder of Thymmune Therapeutics, a biotechnology company developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. The company's cutting-edge approach in iPSC-thymic cell manufacturing can generate off-the-shelf cells at scale for a pipeline of therapies to treat immunodeficiencies, transplant related, and autoimmune disorders. Previously, he was Founding Chief Scientific Officer at Cellino Biotech.
Dr. Wang received his PhD in stem cell biology & regenerative medicine from the University of Cambridge as a Gates Scholar and NIH-Cambridge Scholar, and his MD from Columbia University via the NIH Medical Scientist Training Program. He was a postdoctoral fellow with George Church at Harvard Medical School.
Powered by: Hyphen Projects | Let's connect: |
Book a ticket
| |||
FAQ Contact Us Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 VAT no: NL8184.34.491.B01 |
|
Keep me informed
Download our event app
|
© Copyright 2023 by Hyphen Projects